... of Sciences, suggest that insulin isn't the only agent that is effective. Leptin, a hormone produced by the body ... be a tremendous advance would be the ability to give an oral agent that suppresses glucagon without injections ...
... morality [death] compared with any other oral diabetes agent or placebo; the results for cardiovascular morbidity ... al noted that, when it comes to choosing the safest oral agents, the quality of the data are problematic," writes ...
... of this phase II study showed that the investigational oral agent tetrahydrobiopterin is safe and well-tolerated ... how survival rates are affected by the use of erythropoiesis-stimulating agents (ESAs) for the treatment of anemia in patients with cancer ...
... to intravenous chemotherapy, a new effective oral agent for multi-drug treatment would be useful in treating older women with breast cancer. But the study ...
... expensive, and insurance coverage for these expensive oral chemo agents is spotty, leaving many patients to pay ... of their tamoxifen prescriptions had an increased risk of death. With more oral agents coming to market each year ...
... (VEGF) receptor tyrosine kinases. It is an investigational, oral agent that is administered once daily. Using a form ... as after a single dose of cediranib, those patients who benefited from the agent and those who did not. "We found that results from an advanced MRI scan ...
... Inorganic Chemistry, describe new agents which can be given orally in pill form, which would more expedient ... antioxidants are very effective, but there has also been a desire to have agents that can be given orally. A pill would be more feasible than an injection ...
... extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant ... extract or placebo. Participants took the extract, an oral agent, for three months at one of three doses ...
... formulations, but longer-term users (more than one year) of the oral agents had a 35% increased risk. The authors conclude: "Our study suggests that the use of transdermal oestrogen replacement ...
... England Journal of Medicine. Everolimus, an immunosuppressant agent first used to prevent rejection of organ transplants ... breast cancer, explained Hortobagyi. Currently, the oral agent is approved for both the treatment of kidney ...
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails [...]
... the active drug. "This trial with a well-tolerated oral agent slowed the progression of the disease while helping to delay suffering and maintaining quality of life ...
... new oral agent under review by the U.S. Food and Drug Administration (FDA) is safe and effective in treating ...
